Another study revealed that the hyaluronic acid family could be used as a BLCA biomarker, whose expression positively correlated with transcriptional regulators such as β-catenin, Twist, and Snail expression levels [37]. This evidence concerns the gene SNAI1 and bladder transitional cell carcinoma.